This product is applicable to the qualitative detection of novel coronavirus (SARS-CoV-2) neutralizing antibodies in patients who have recovered from naturally infected with SARS- CoV-2 or those who have been vaccinated.
■ Intended Use
This product is applicable to the qualitative détection of novel coronavirus (SARS-CoV-2) neutralizing antibodies in patients who have recovered from naturally infected with SARS-CoV-2 or those who have been vaccinated.
Human immunity is assessed by testing for the presence of novel Coronavirus (SARS-CoV-2) neutralizing antibodies in sérum, plasma and whole blood samples of people infected with COVID-19 or immunized with vaccine.
■ Necessary
Neutralizing antibody détection has always played an important rôle in evaluating the level of human immune response after vaccination in the évaluation of vaccine effectiveness.
Neutralizing antibodies can prevent the Novel Coronavirus from binding to receptors on the cell surface, thereby directly preventing the virus from infecting cells. This means that the body could fight off new infections in the future with neutralizing antibodies.
It can accurately detect the presence of neutralizing antibodies and their ability to determine whether a body has built up immunity against the Novel coronavirus.